FDA approves new 3D OCT system

The FDA has cleared the 3D OCT-1 Maestro system (Topcon Medical Systems), a spectral domain-OCT equipped with PinPoint registration, allowing the user to indicate the location of the OCT image within the fundus image.

The Maestro system also features a compare function, automatic segmentation of the optic nerve and macula in a 12mm by 9mm scan, as well as an extensive reference database. Topcon reports that is has sold more than 10,000 units worldwide.

“The Maestro has been one of the best-selling SD OCTs outside the United States for the past 2 years and we are pleased that the recent FDA Clearance of the Maestro will now enable US eye care professionals to experience the benefits of the Maestro and contribute to their patient’s overall eye health and well-being,” stated John Fujita, president of Topcon Medical Systems.